Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Valneva updates share and voting rights status as of May 31, 2026, with minor changes in voting rights.

Company Fundamentals
03 Jun 2026
Na
View Source
Neutral
pluang ai news

Valneva announced an update on its share capital and voting rights as of May 31, 2026. The company reported a total of 189,771,237 ordinary shares with a nominal value of €0.15 each, and a total of 204,363,287 voting rights including suspended rights. The change involved the conversion of 1,859 ordinary shares to double voting rights between May 7 and May 30, 2026. This update is part of regulatory compliance and reflects the current shareholder structure ahead of upcoming corporate activities.

More News

Valneva reports 204.2M exercisable voting rights as of May 31, 2026, reflecting share capital status.

Valneva reports 204.2M exercisable voting rights as of May 31, 2026, reflecting share capital status.

Valneva declared its shares and voting rights status as of May 31, 2026, reporting 189,771,237 ordinary shares and a total of 204,238,965 exercisable voting rights after accounting for double voting rights on some shares. This update is important for...

Company Fundamentals
Neutral
15 minutes ago
Integrated Quantum launches VEIL™ on Snowflake AI Data Cloud to secure sensitive data by removing PII for safer AI use.

Integrated Quantum launches VEIL™ on Snowflake AI Data Cloud to secure sensitive data by removing PII for safer AI use.

Integrated Quantum Technologies introduced VEIL™, a privacy-focused tool integrated into Snowflake's AI Data Cloud, which removes personally identifiable information (PII) from data before it is used in AI and machine learning models. This approach a...

Market News
Bullish
24 minutes ago
Bluejay Diagnostics raises $23.6M, partners with Argonaut to boost US manufacturing and prepare for FDA submission.

Bluejay Diagnostics raises $23.6M, partners with Argonaut to boost US manufacturing and prepare for FDA submission.

Bluejay Diagnostics announced a private placement to raise up to $23.6 million, including $8.5 million upfront, to extend its cash runway into early 2027. The funds will support FDA submission and commercialization of its rapid sepsis testing system,...

Market News
Bullish
26 minutes ago
Ed Yardeni predicts a Fed rate hike in July, defying market consensus expecting no change.

Ed Yardeni predicts a Fed rate hike in July, defying market consensus expecting no change.

Ed Yardeni, president of Yardeni Research, forecasts the Federal Reserve will raise interest rates at its July 29 meeting, a view that contrasts with the market's low expectations for a rate hike this summer. Yardeni cites a resilient economy, strong...

Market News
Neutral
36 minutes ago
Veeva Systems eyes $857M Q1 revenue amid platform shift and AI expansion ahead of June earnings.

Veeva Systems eyes $857M Q1 revenue amid platform shift and AI expansion ahead of June earnings.

Veeva Systems is preparing to report Q1 earnings on June 3, 2026, with revenue guidance between $855M and $858M and an EPS estimate of $2.13, reflecting year-over-year growth. The company is transitioning from Salesforce to its own Vault CRM platform...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App